SCHEMBL35587

SCHEMBL35587

C=CC(=O)NCCC[N+](C)(C)CCCS(=O)(=O)[O-]

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
BBOX1 O75936 3/20 0.47
ZDHHC20 Q5W0Z9 1/20 0.45
ZDHHC2 Q9UIJ5 1/20 0.45
KMT2A Q03164 2/20 0.45
ATM Q13315 1/20 0.45
CBLB Q13191 5/20 0.39
EPHX2 P34913 1/20 0.38
ALDH1A1 P00352 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
GRK2 P25098 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16799402 0.96 ZDHHC20 (0.47) BBOX1ZDHHC20ZDHHC2KMT2AATM
SCHEMBL12002727 0.96 ZDHHC20 (0.44) BBOX1ZDHHC20ZDHHC2KMT2AATM
SCHEMBL16798893 0.94 ZDHHC20 (0.46) BBOX1ZDHHC20ZDHHC2KMT2AATM
SCHEMBL18151868 0.94 ZDHHC20 (0.46) BBOX1ZDHHC20ZDHHC2KMT2AATM
SCHEMBL18151884 0.94 ZDHHC20 (0.46) BBOX1ZDHHC20ZDHHC2KMT2AATM
SCHEMBL18151501 0.94 ZDHHC20 (0.50) BBOX1ZDHHC20ZDHHC2KMT2AATM
SCHEMBL16799349 0.94 ZDHHC20 (0.46) BBOX1ZDHHC20ZDHHC2KMT2AATM
SCHEMBL16799362 0.94 ZDHHC20 (0.50) BBOX1ZDHHC20ZDHHC2KMT2AATM
SCHEMBL16799292 0.94 ZDHHC20 (0.50) BBOX1ZDHHC20ZDHHC2KMT2AATM
SCHEMBL16799421 0.94 ZDHHC20 (0.50) BBOX1ZDHHC20ZDHHC2KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 570 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12638614-B2 Method for making silicone hydrogel contact lenses ALCON INC. (CH) 2026-05-26 US claimed
EP-4514596-B1 METHOD FOR MAKING SILICONE HYDROGEL CONTACT LENSES ALCON INC (CH) 2026-03-04 EP claimed
US-20250263512-A1 POLYMER COMPOSITIONS CONTAINING GRAFTED POLYMERIC NETWORKS AND PROCESSES FOR THEIR PREPARATION AND USE JOHNSON & JOHNSON VISION CARE (US) 2025-08-21 US claimed
WO-2025065051-A1 PLASMA-MEDIATED POLYMER GRAFTING METHODOLOGY THE UNIVERSITY OF SYDNEY (AU) 2025-04-03 WO claimed
EP-4520795-A1 ANTIFOULING MEMBER, MEMBER FOR IN-VITRO DIAGNOSTIC APPARATUS, AND METHOD OF PRODUCING ANTIFOULING MEMBER CANON KABUSHIKI KAISHA (JP) 2025-03-12 EP claimed
US-12247169-B2 Method for making photochromic contact lenses ALCON INC. (CH) 2025-03-11 US claimed
US-20250075095-A1 ANTIFOULING MEMBER, MEMBER FOR IN-VITRO DIAGNOSTIC APPARATUS, AND METHOD OF PRODUCING ANTIFOULING MEMBER CANON KABUSHIKI KAISHA (JP) 2025-03-06 US claimed
EP-4514596-A1 METHOD FOR MAKING SILICONE HYDROGEL CONTACT LENSES Alcon Inc. (CH) 2025-03-05 EP claimed
EP-4514597-A1 METHOD FOR MAKING UV AND HEVL-ABSORBING OPHTHALMIC LENSES Alcon Inc. (CH) 2025-03-05 EP claimed
EP-4499278-A1 BARRIERS INCLUDING BIOLOGICAL NANOPORE FOR DNA SEQUENCING, THE BARRIERS BEING MADE OF CO-POLYMERS WITH END AND/OR MIDDLE GROUPS, AND METHODS OF MAKING THE SAME ILLUMINA, INC. (US) 2025-02-05 EP claimed
EP-2855547-A2 POLYMERS AND NANOGEL MATERIALS AND METHODS FOR MAKING AND USING THE SAME Johnson & Johnson Vision Care Inc. (US) 2015-04-08 EP claimed
WO-2013176886-A2 POLYMERS AND NANOGEL MATERIALS AND METHODS FOR MAKING AND USING THE SAME JOHNSON & JOHNSON VISION CARE, INC. (US) 2013-11-28 WO claimed
US-20130317131-A1 POLYMERS AND NANOGEL MATERIALS AND METHODS FOR MAKING AND USING THE SAME JOHNSON & JOHNSON VISION CARE, INC. (US) 2013-11-28 US claimed
WO-2013177523-A2 POLYMERS AND NANOGEL MATERIALS AND METHODS FOR MAKING AND USING THE SAME JOHNSON & JOHNSON VISION CARE, INC. (US) 2013-11-28 WO claimed
US-20130217620-A1 IONIC SILICONE HYDROGELS JOHNSON & JOHNSON VISION CARE, INC. (US) 2013-08-22 US claimed
US-20130168617-A1 IONIC SILICONE HYDROGELS JOHNSON & JOHNSON VISION CARE, INC. (US) 2013-07-04 US claimed
EP-1157050-B1 ZWITTERION DERIVATIVES AND APPLICATION TO AQUEOUS SUSPENSION PROPERTIES INST FRANCAIS DU PETROLE (FR) 2004-05-06 EP claimed
US-6410671-B1 WATER SOLUBLE COPOLYMER CONTAINING ACRYLAMIDE AND QUATERNARY AMMONIUM COMPOUND INSTITUTE FRANCAIS DU PETROLE (FR) 2002-06-25 US claimed
EP-1157050-A1 ZWITTERION DERIVATIVES AND APPLICATION TO AQUEOUS SUSPENSION PROPERTIES INSTITUT FRANCAIS DU PETROLE (FR) 2001-11-28 EP claimed
WO-2000001746-A1 ZWITTERION DERIVATIVES AND APPLICATION TO AQUEOUS SUSPENSION PROPERTIES INSTITUT FRANCAIS DU PETROLE (FR) 2000-01-13 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130217620-A1 IONIC SILICONE HYDROGELS HACD2, IGFBP2, IGFBP6 BBOX1 3768/4885ZDHHC20 3825/4885ZDHHC2 3836/4885
US-12638614-B2 Method for making silicone hydrogel contact lenses SMCHD1, CRYAA, CRYZ BBOX1 2207/4885ZDHHC20 1842/4885ZDHHC2 2341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.